Neurosurgery Focused Integra LifeSciences Bolsters Its ENT Portfolio With $275M Acquisition Deal
Benzinga
DECEMBER 13, 2023
Integra LifeSciences Holdings Corporation (NASDAQ: IART ) agreed to acquire Acclarent Inc. from Ethicon Inc , a Johnson & Johnson (NYSE: JNJ ) MedTech company, for $275 million in cash, and an additional $5 million upon the achievement of certain regulatory milestones. Acclarent offers medical devices for ENT procedures.
Let's personalize your content